Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |